![Criteria, Challenges, and Opportunities for Acellularized Allogeneic/Xenogeneic Bone Grafts in Bone Repairing | ACS Biomaterials Science & Engineering Criteria, Challenges, and Opportunities for Acellularized Allogeneic/Xenogeneic Bone Grafts in Bone Repairing | ACS Biomaterials Science & Engineering](https://pubs.acs.org/cms/10.1021/acsbiomaterials.2c00194/asset/images/large/ab2c00194_0011.jpeg)
Criteria, Challenges, and Opportunities for Acellularized Allogeneic/Xenogeneic Bone Grafts in Bone Repairing | ACS Biomaterials Science & Engineering
Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials | PLOS ONE
![B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches | Leukemia B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41375-020-0734-z/MediaObjects/41375_2020_734_Fig1_HTML.png)
B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches | Leukemia
![Focus on monoclonal antibodies targeting B‐cell maturation antigen (BCMA) in multiple myeloma: update 2021 - Demel - 2021 - British Journal of Haematology - Wiley Online Library Focus on monoclonal antibodies targeting B‐cell maturation antigen (BCMA) in multiple myeloma: update 2021 - Demel - 2021 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/cc243693-bdc8-49b4-8444-8207e37323f1/bjh17235-fig-0003-m.jpg)